188 related articles for article (PubMed ID: 36271335)
1. An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding.
Chiang HC; Yang EH; Hu HM; Chen WY; Chang WL; Wu CT; Wu DC; Sheu BS; Cheng HC
BMC Gastroenterol; 2022 Oct; 22(1):439. PubMed ID: 36271335
[TBL] [Abstract][Full Text] [Related]
2. Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study.
Cheng HC; Wu CT; Chang WL; Cheng WC; Chen WY; Sheu BS
Gut; 2014 Dec; 63(12):1864-72. PubMed ID: 24658598
[TBL] [Abstract][Full Text] [Related]
3. Peptic ulcer bleeding patients with Rockall scores ≥6 are at risk of long-term ulcer rebleeding: A 3.5-year prospective longitudinal study.
Yang EH; Cheng HC; Wu CT; Chen WY; Lin MY; Sheu BS
J Gastroenterol Hepatol; 2018 Jan; 33(1):156-163. PubMed ID: 28497645
[TBL] [Abstract][Full Text] [Related]
4. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6.
Yang EH; Wu CT; Kuo HY; Chen WY; Sheu BS; Cheng HC
Surg Endosc; 2020 Apr; 34(4):1592-1601. PubMed ID: 31222633
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.
Bai Y; Chen DF; Wang RQ; Chen YX; Shi RH; Tian DA; Chen H; Eklund S; Li ZS;
Adv Ther; 2015 Nov; 32(11):1160-76. PubMed ID: 26581750
[TBL] [Abstract][Full Text] [Related]
6. Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding.
Lau J; Lind T; Persson T; Eklund S
J Dig Dis; 2017 Feb; 18(2):99-106. PubMed ID: 28070941
[TBL] [Abstract][Full Text] [Related]
7. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
[TBL] [Abstract][Full Text] [Related]
8. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.
Tsai JJ; Hsu YC; Perng CL; Lin HJ
Br J Clin Pharmacol; 2009 Mar; 67(3):326-32. PubMed ID: 19523014
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
Jensen DM; Eklund S; Persson T; Ahlbom H; Stuart R; Barkun AN; Kuipers EJ; Mössner J; Lau JY; Sung JJ; Kilhamn J; Lind T
Am J Gastroenterol; 2017 Mar; 112(3):441-446. PubMed ID: 28094314
[TBL] [Abstract][Full Text] [Related]
10. Esomeprazole for the treatment of peptic ulcer bleeding.
den Hoed CM; Kuipers EJ
Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
[TBL] [Abstract][Full Text] [Related]
11. Once Versus Twice-Daily Oral Proton Pump Inhibitor Therapy for Prevention of Peptic Ulcer Rebleeding: A Propensity Score-Matched Analysis.
Ayoub F; Khullar V; Banerjee D; Stoner P; Lambrou T; Westerveld DR; Hanayneh W; Kamel AY; Estores D
Gastroenterology Res; 2018 Jun; 11(3):200-206. PubMed ID: 29915630
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Leontiadis GI; Sharma VK; Howden CW
Cochrane Database Syst Rev; 2010 May; 2010(5):CD002094. PubMed ID: 20464720
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
[TBL] [Abstract][Full Text] [Related]
15. Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.
Sachar H; Vaidya K; Laine L
JAMA Intern Med; 2014 Nov; 174(11):1755-62. PubMed ID: 25201154
[TBL] [Abstract][Full Text] [Related]
16. High- versus low-dose proton pump inhibitors post endoscopic hemostasis in hemodialysis cases with peptic ulcer bleeding.
Salman AA; Salman MA; Sarhan MD; Shaaban HE; Yousef M; Ibrahim A; Tourky M; Youssef A; Sherbiny ME
Acta Gastroenterol Belg; 2021; 84(1):3-8. PubMed ID: 33639687
[TBL] [Abstract][Full Text] [Related]
17. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.
Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ
BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960
[TBL] [Abstract][Full Text] [Related]
18. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use.
Cheng HC; Yang EH; Wu CT; Wang WL; Chen PJ; Lin MY; Sheu BS
J Formos Med Assoc; 2018 Apr; 117(4):316-325. PubMed ID: 28751088
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
20. Continuous esomeprazole infusion versus bolus administration and second look endoscopy for the prevention of rebleeding in children with a peptic ulcer.
Belei O; Olariu L; Puiu M; Jinca C; Dehelean C; Marcovici T; Marginean O
Rev Esp Enferm Dig; 2018 Jun; 110(6):352-357. PubMed ID: 29465250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
